tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Dennis Ding, 17 are a BUY (51.52%), 16 are a HOLD (48.48%).
Analyst Dennis Ding, currently employed at JEFFERIES, carries an average stock price target met ratio of 71.05% that have a potential upside of 25.58% achieved within 179 days.
Dennis Ding’s has documented 65 price targets and ratings displayed on 20 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on CRNX, Crinetics Pharmaceuticals at 07-Jul-2026.
Analyst best performing recommendations are on MIST (MILESTONE PHARMACEUTICALS).
The best stock recommendation documented was for NGM (NGM BIOPHARMACEUTICALS) at 10/17/2022. The price target of $4 was fulfilled within 3 days with a profit of $0.59 (17.3%) receiving and performance score of 57.67.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 15-Sep-2020
$5
$0.42 (9.17%)
$5
8 months 16 days ago
(14-Nov-2025)
4/14 (28.57%)
$0.48 (10.62%)
136
Buy Since 05-Nov-2021
$5
$0.42 (9.17%)
$5
1 years 3 months 29 days ago
(31-Mar-2025)
2/10 (20%)
$1.51 (43.27%)
256
Buy Since 17-Dec-2020
$5
$0.42 (9.17%)
$5
1 years 6 months 9 days ago
(21-Jan-2025)
0/18 (0%)
$1.79 (55.76%)
Buy Since 02-Feb-2022
$5
$0.71 (16.55%)
$4
4 years 5 months 28 days ago
(02-Feb-2022)
1/2 (50%)
$2.11 (73.01%)
980
Buy Since 05-Mar-2020
$7
5 years 1 months 2 days ago
(28-Jun-2021)
0/4 (0%)
$3.7 (112.12%)
Which stock is Dennis Ding is most bullish on?
What Year was the first public recommendation made by Dennis Ding?
